These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 16619495)

  • 21. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas.
    Lebeau A; Nerlich AG; Sauer U; Lichtinghagen R; Löhrs U
    Anticancer Res; 1999; 19(5B):4257-64. PubMed ID: 10628384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
    Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
    J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrilysin expression in human prostate carcinoma.
    Knox JD; Wolf C; McDaniel K; Clark V; Loriot M; Bowden GT; Nagle RB
    Mol Carcinog; 1996 Jan; 15(1):57-63. PubMed ID: 8561867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
    Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
    Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
    Tang Y; Kesavan P; Nakada MT; Yan L
    Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of MMP-2 expression in prostate cancer: an immunohistochemical study.
    Trudel D; Fradet Y; Meyer F; Harel F; Têtu B
    Cancer Res; 2003 Dec; 63(23):8511-5. PubMed ID: 14679018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finasteride treatment alters MMP-2 and -9 gene expression and activity in the rat ventral prostate.
    Delella FK; Justulin LA; Felisbino SL
    Int J Androl; 2010 Feb; 33(1):e114-22. PubMed ID: 19508332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome.
    Kerkelä E; Ala-aho R; Klemi P; Grénman S; Shapiro SD; Kähäri VM; Saarialho-Kere U
    J Pathol; 2002 Oct; 198(2):258-69. PubMed ID: 12237887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers.
    Kuniyasu H; Troncoso P; Johnston D; Bucana CD; Tahara E; Fidler IJ; Pettaway CA
    Clin Cancer Res; 2000 Jun; 6(6):2295-308. PubMed ID: 10873080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis.
    Pap T; Shigeyama Y; Kuchen S; Fernihough JK; Simmen B; Gay RE; Billingham M; Gay S
    Arthritis Rheum; 2000 Jun; 43(6):1226-32. PubMed ID: 10857781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
    Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
    Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
    Hu J; Zhang X; Nothnick WB; Spencer TE
    Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes.
    Kouwenhoven M; Ozenci V; Gomes A; Yarilin D; Giedraitis V; Press R; Link H
    J Autoimmun; 2001 Jun; 16(4):463-70. PubMed ID: 11437495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis.
    Cai KQ; Yang WL; Capo-Chichi CD; Vanderveer L; Wu H; Godwin AK; Xu XX
    Mol Carcinog; 2007 Feb; 46(2):130-43. PubMed ID: 17131304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma.
    Isaka K; Nishi H; Nakai H; Nakada T; Feng Li Y; Ebihara Y; Takayama M
    Cancer; 2003 Jan; 97(1):79-89. PubMed ID: 12491508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
    Paradis V; Dargère D; Laurendeau I; Benoît G; Vidaud M; Jardin A; Bedossa P
    J Pathol; 1999 Oct; 189(2):213-8. PubMed ID: 10547577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue.
    Lichtinghagen R; Musholt PB; Stephan C; Lein M; Kristiansen G; Hauptmann S; Rudolph B; Schnorr D; Loening SA; Jung K
    Anticancer Res; 2003; 23(3B):2617-24. PubMed ID: 12894549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
    Kong L; Li Q; Wang L; Liu Z; Sun T
    Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
    Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
    Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.